Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma.

Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma. Abstract Text:

Rajagopalan Sudha,Nicole Kawachi,Peicheng Du,Edward Nieves,Thomas J Belbin,Abdissa Negassa,Ruth Hogue Angeletti,Michael B Prystowsky,

The goal of this study was to establish a method for detecting biologically significant differences in protein expression of head and neck squamous cell carcinoma (HNSCC) obtained from the same samples utilized in gene expression analyses. Proteins from two head and neck tumor cell lines, SCC-25 and FaDu, were isolated from the denatured protein solution remaining from the TRIzol extraction procedure used for isolation of total RNA for microarray analysis. Peptides resulting from chemical and enzymatic digestion of the proteins were first separated by strong cation-exchange chromatography, followed by liquid chromatography-mass spectrometry (LC-MS) analysis on a QqTOF mass spectrometer. Stable isotope-labeled synthetic peptides were added to each ion-exchange fraction as internal standards, for reversed-phase HPLC retention time alignment. Protein extraction and digestion were repeated three times for each cell line and each extract was analyzed three times by LC-MS. To discriminate between technical vs biological variation, the ion-exchange fraction, retention time, normalized mass and signal intensity of these nine data sets were constructed into numerical arrays for statistical analysis. Of the approximately 50,000 signals, 90 peptide ions were found to discriminate the two cell lines with high stringency. Of those, six peptides were derived from vimentin and four peptides were derived from annexin II; both expressed more in SCC-25. Follow-up analysis of some of these signals by LC-MS/MS and RNA expression profiling revealed both concordance and discordance of RNA and protein expression. This study demonstrates that this procedure is highly reliable for identifying peptides that distinguish biological variability among samples, indicating that this method can be applied to study clinical samples, to identify potential prognostic biomarkers for HNSCC.

Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma. Publishing Authors By Initials

R Sudha,N Kawachi,P Du,E Nieves,TJ Belbin,A Negassa,RH Angeletti,MB Prystowsky,

For similar neoplasms: neoplasms by site: head and neck neoplasms: mouth neoplasms: tongue neoplasms research abstracts see: neoplasms: neoplasms by site: head and neck neoplasms: mouth neoplasms: tongue neoplasms research

PUBMED ID PMID:

MEDLINE DATE:

Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Laboratory investigation; a journal of technical m

VOLUME: 87

Page Numbers: 755-66

Journal Abbreviation: Lab. Invest.

ISSN: 0023-6837

DAY: 11

MONTH: 06

YEAR: 2007

Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 376617

Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma. Keywords Mesh Terms:

KEYWORDS: Tongue Neoplasms

MESH TERMS: metabolism

Chemical & Substance for Abstract: Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma. Information

Substance Name: RNA

Registry Number: 63231-63-0

Grant and Affiliation Information for Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma.

AFFILIATION: Department of Pathology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USA.

Country: United States

AGENCY: United States NCI

GRANT: CA103547

ACRONYM: CA

MEDLINETA: Lab Invest

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma Related Publications

• A STUDY OF THE ACID-BASE BALANCE OF THE FETUS AND NEWBORN AND ITS RELATION TO THAT OF THE MOTHER.
• Advances in the genetics of sarcoidosis.
• Atrial fibrillation: goals of therapy and management strategies to achieve the goals.
• Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2.
• Complications associated with generator replacement in response to device advisories.
• Epidermodysplasia verruciformis.
• Fibrinolytic therapy for vasculitis of atrophie blanche.
• Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma.
• Glutaraldehyde (pentanedial) allergic contact dermatitis. Usage test on sole and antecubital fossa: regional variations in response.
• Mixed connective tissue disease syndrome.
• Mixed connective tissue disease.
• Photoprotection and the vitamin D status of the elderly. A concern for dermatologists.
• Postoperative hypoxemia in morbidly obese patients with and without obstructive sleep apnea undergoing laparoscopic bariatric surgery.
• Systemic lupus erythematosus with generalized chronic cutaneous (discoid) lupus erythematosus.
• The attraction of MD-PhDs to dermatology.
• The history of atrial fibrillation: the last 100 years.